GI practices bill from a narrower code set than most specialties, which means their denial patterns cluster tightly. Four issues drive the bulk of gastroenterology write-offs: screening-to-diagnostic reclassification on colonoscopies, CO-97 bundling of polypectomy codes, medical necessity challenges on upper endoscopy, and multiple-procedure sequencing errors on two-scope sessions. Each has a specific fix.
The screening-to-diagnostic conversion
Under ACA preventive-care requirements, colorectal cancer screening colonoscopies are covered without patient cost-sharing for non-grandfathered plans. When a polyp is discovered and removed during the same session, some payers reclassify the claim from a screening code (G0105 or G0121) to a therapeutic code (45385 or 45388) and apply the patient's deductible and copay. The patient receives a bill they never expected and the practice fields the complaint.
Federal guidance effective for plan years beginning after May 31, 2022 generally requires that cost-sharing not be imposed when polyp removal occurs during a covered preventive colonoscopy. Compliance from payers has been uneven. The appeal argument is direct: cite the applicable regulatory guidance, attach the operative report confirming the procedure began as a scheduled screening, and submit through the plan's contract dispute channel. For Texas state-regulated commercial plans, the Texas prompt-pay escalation sequence is available if the payer does not correct the reclassification.
CO-97 and polypectomy bundling
Colonoscopy CPT codes are procedure-specific: 45385 covers snare polypectomy, 45388 covers ablation, and neither is included in the base diagnostic code (45378) or the G-codes for screening. Despite this, some payers bundle the polypectomy line into the base scope code as CO-97, treating removal as part of the original examination.
- Check the payer's own fee schedule first. If the payer separately prices 45385 or 45388, the bundling is incorrect and the appeal cites the payer's own allowable list.
- Look up the NCCI modifier indicator. The CMS National Correct Coding Initiative table assigns each code pair an indicator of "1" (modifier override allowed) or "0" (no override). A modifier 59 or an X-modifier resolves a "1" edit; a "0" edit is not appellable on bundling grounds.
- Include the operative report. Documentation confirming that the polypectomy was a distinct technical act at an anatomically separate site from the initial examination supports the claim that the codes describe non-overlapping work.
Upper endoscopy and CO-50
EGD claims (CPT 43235 series) draw CO-50 medical necessity denials when the procedure note documents a symptom without enough clinical context to justify the scope. Payer criteria generally require evidence that less invasive management was tried first and that a specific clinical concern, not general discomfort, drove the decision.
A CO-50 appeal for upper endoscopy should include three things:
- Duration and severity of the presenting symptom: dysphagia, refractory GERD, unexplained weight loss, or documented concern for Barrett's esophagus.
- Documentation of failed or inadequate empiric treatment: what was tried, for how long, and what the outcome was.
- The treating physician's explicit reasoning for proceeding to endoscopy rather than continuing medication management. Payers look for a clinical decision, not a symptom list.
A note that reads "GERD, refer to GI" will lose. One that reads "refractory GERD on twice-daily PPI for 10 weeks, concern for Barrett's esophagus given duration and family history" gives the appeal a foundation the payer's reviewer can engage with.
Two-scope sessions and modifier 51
When a patient undergoes both an upper endoscopy and a colonoscopy in the same session, multiple-procedure rules apply. Modifier 51 (multiple procedures, same provider, same day) signals that the second procedure was performed at the same encounter. Without it, one of the procedures may bundle into the other as CO-97.
Payers typically pay the higher-valued procedure at 100% and the secondary at a reduced rate, commonly 50%. Check the ERA to confirm which code paid and which bundled. If the more expensive code bundled into the less expensive one, the claim was sequenced incorrectly. Appeal with the correct claim sequence, modifier 51 on the secondary procedure line, and the operative report confirming both procedures were separately documented and medically indicated.
Why these patterns add up
GI procedures carry relatively high allowed amounts, so each of these denial patterns is worth recovering. A screening-to-diagnostic reclassification on a colonoscopy can involve several hundred dollars in disputed cost-shifting. A CO-97 polypectomy write-off loses the full allowed amount for the additional code. An EGD bundled into a colonoscopy on a two-scope day loses the second procedure's payment entirely.
Because the same denial pattern typically applies to the same payer across all patients, systematic detection and batch appeal is more efficient than case-by-case review. Audit remittances at the service-line level to surface the silent write-offs that never enter a standard work queue, and group findings by payer and code to identify which carrier is applying which policy before drafting the first appeal letter.